Injective (INJ) experienced a sharp 19% drop in price over the past day as the broader crypto market entered a correction phase. This decline is accompanied by a significant reduction in trading volume, falling to $174 million, indicating waning market participation and buyer hesitation. The token broke below a key EMA support, signaling strong selling pressure with bears currently in control. Unless overall crypto market sentiment improves, INJ may continue to face downward pressure, with buyers yet to show strong interest for a rebound.
Merkle Capital, a Thailand-based digital asset manager, has launched M-INJ, Asia's first regulated investment fund focused solely on Injective's native token, INJ. Approved by Thailand's Securities and Exchange Commission, the fund offers both retail...
Siren (SIREN) surged 29.65% to $0.7415 following recent platform upgrades that improved its efficiency, signaling rising interest in decentralized finance. Meanwhile, LAB experienced a sharp decline of 36.95% to $10.89 due to a significant sell-off i...
Injective (INJ) overcame a prolonged downtrend by breaking the key $6.29 resistance level, signaling renewed buyer confidence after a low near $2.61. Despite a recent 5% pullback as short-term holders took profits and Bitcoin corrected, the RSI near ...
